School of Women's and Children's Health, University of New South Wales.
Gynaecological Research and Clinical Evaluation (GRACE) Unit, Royal Hospital for Women, Sydney, New South Wales, Australia.
Curr Opin Obstet Gynecol. 2024 Oct 1;36(5):353-361. doi: 10.1097/GCO.0000000000000983. Epub 2024 Aug 17.
While laparoscopic surgery plays a key role in the management of endometriosis, symptoms commonly recur, and repeat surgery comes with increased risk. Medical management, including hormonal and nonhormonal treatment, is vital in managing painful symptoms. This review summarizes recent evidence regarding various medical management options available to treat pelvic pain associated with endometriosis.
Efficacy of dienogest vs. combined oral contraceptive on pain associated with endometriosis: randomized clinical trial.Once daily oral relugolix combination therapy vs. placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2).A randomized, double-blind, placebo-controlled pilot study of the comparative effects of dienogest and the combined oral contraceptive pill in women with endometriosis.Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study.
All symptomatic women with suspected endometriosis who are not desiring immediate fertility can be offered suppressive treatment to control symptoms and slow the progression of disease. First-line treatments include the combined oral contraceptive pill and progestogens. Second-line treatments include gonadotropin-releasing hormone agonists and antagonists but current guidelines recommend that these should be reserved for people whose symptoms fail to be controlled by first-line agents. The use of complementary and alternative medicines is also increasing in both volume and number of agents used.
腹腔镜手术在子宫内膜异位症的治疗中起着关键作用,但症状通常会复发,重复手术的风险增加。药物治疗,包括激素和非激素治疗,对于治疗疼痛症状至关重要。本文综述了最近关于各种治疗子宫内膜异位症相关盆腔疼痛的药物治疗选择的证据。
地诺孕素与复方口服避孕药治疗子宫内膜异位症相关疼痛的疗效:随机临床试验。每日一次口服瑞戈非尼联合治疗与安慰剂治疗子宫内膜异位症相关疼痛的患者:两项复制的 3 期、随机、双盲、研究(SPIRIT1 和 2)。地诺孕素和复方口服避孕药治疗子宫内膜异位症妇女的比较效果的随机、双盲、安慰剂对照初步研究。在患有子宫内膜异位症相关疼痛的女性中,瑞戈非尼联合治疗的两年疗效和安全性:SPIRIT 开放性扩展研究。
所有有症状且疑似患有子宫内膜异位症但不希望立即生育的女性都可以接受抑制性治疗以控制症状并减缓疾病的进展。一线治疗包括复方口服避孕药和孕激素。二线治疗包括促性腺激素释放激素激动剂和拮抗剂,但目前的指南建议,这些药物应保留给那些一线药物治疗无效的患者。补充和替代药物的使用也在增加,无论是在数量还是在使用的药物种类上。